Celsion Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CLSN Nasdaq 2834 http://celsion.com/ 3.97 Stock Up +0.02

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Celsion Corporation

Celsion Corporation to Hold Year-End 2013 Financial Results Conference Call on Thursday, March 13, 2014 - Mar 6th, 2014 6:12 am
Celsion Corporation to Hold Year-End 2013 Financial Results Conference Call on Thursday, March 13, 2014 - Mar 6th, 2014 6:00 am
Celsion Announces Positive Interim Data from Phase 2 DIGNITY Trial in Breast Cancer - Feb 27th, 2014 2:46 pm
Celsion Announces Positive Interim Data from Phase 2 DIGNITY Trial in Breast Cancer - Feb 27th, 2014 2:05 pm
Celsion's OPTIMA Study: What You Need To Know - Feb 26th, 2014 9:01 am
Celsion Announces FDA Clearance of the OPTIMA Study - A Pivotal Phase III Trial of ThermoDox in Primary Liver Cancer - Feb 24th, 2014 10:24 am
Celsion Announces FDA Clearance of the OPTIMA Study - A Pivotal Phase III Trial of ThermoDox in Primary Liver Cancer - Feb 24th, 2014 6:00 am
Celsion's Newest Cancer Treatment Adds To Upside - Feb 13th, 2014 2:37 pm
Data on Celsion's ThermoDox - Jan 28th, 2014 2:40 pm
Celsion plans new study of liver cancer drug - Jan 27th, 2014 9:51 am
Celsion plans new study of liver cancer drug - Jan 27th, 2014 9:51 am
Celsion Provides Encouraging Post-Hoc O/S Data From HEAT Trial - Jan 27th, 2014 9:05 am
Celsion Corporation Announces Updated Overall Survival Results from Phase III HEAT Study of ThermoDox® in Primary Liver Cancer - Jan 27th, 2014 6:00 am
CELSION CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E - Jan 21st, 2014 2:05 pm
Celsion Corporation Initiates Development Program for Glioblastoma Brain Tumors with ThermoDox® and HIFU - Jan 21st, 2014 6:10 am
Celsion Corporation Initiates Development Program for Glioblastoma Brain Tumors with ThermoDox® and HIFU - Jan 21st, 2014 6:00 am
2 Biotech Stocks in Play: Celsion and Chelsea - Jan 15th, 2014 9:14 am
Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering - Jan 15th, 2014 8:14 am
CELSION CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits - Jan 15th, 2014 7:32 am
Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering - Jan 15th, 2014 7:07 am